TET vs. ELM, VCT, SCPA, ESNT, SYNT, ZTF, IOF, WCH, ITX, and DCTA
Should you be buying Treatt stock or one of its competitors? The main competitors of Treatt include Elementis (ELM), Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Synthomer (SYNT), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry.
Treatt vs.
Elementis (LON:ELM) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.
Elementis presently has a consensus price target of GBX 170, indicating a potential upside of 6.25%. Treatt has a consensus price target of GBX 650, indicating a potential upside of 53.99%. Given Treatt's higher possible upside, analysts clearly believe Treatt is more favorable than Elementis.
Treatt has a net margin of 7.88% compared to Elementis' net margin of -4.74%. Treatt's return on equity of 8.09% beat Elementis' return on equity.
Elementis pays an annual dividend of GBX 3 per share and has a dividend yield of 1.9%. Treatt pays an annual dividend of GBX 8 per share and has a dividend yield of 1.9%. Elementis pays out -63.7% of its earnings in the form of a dividend. Treatt pays out 43.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
In the previous week, Elementis and Elementis both had 1 articles in the media. Treatt's average media sentiment score of 1.16 beat Elementis' score of 0.75 indicating that Treatt is being referred to more favorably in the news media.
Treatt has lower revenue, but higher earnings than Elementis. Elementis is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.
73.7% of Elementis shares are owned by institutional investors. Comparatively, 50.9% of Treatt shares are owned by institutional investors. 4.2% of Elementis shares are owned by insiders. Comparatively, 13.4% of Treatt shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Elementis received 334 more outperform votes than Treatt when rated by MarketBeat users. However, 68.97% of users gave Treatt an outperform vote while only 65.78% of users gave Elementis an outperform vote.
Elementis has a beta of 2.02, meaning that its share price is 102% more volatile than the S&P 500. Comparatively, Treatt has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.
Summary
Treatt beats Elementis on 12 of the 18 factors compared between the two stocks.
Get Treatt News Delivered to You Automatically
Sign up to receive the latest news and ratings for TET and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (LON:TET) was last updated on 2/17/2025 by MarketBeat.com Staff